# A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study)

> **NCT04945018** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Heartseed Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Heart Failure
- Ischemic Heart Disease

## Interventions

- **BIOLOGICAL:** HS-001 CS
- **DEVICE:** HS-001-D needle, HS-001-D Adaptor

## Key facts

- **NCT ID:** NCT04945018
- **Lead sponsor:** Heartseed Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-19
- **Primary completion:** 2025-07-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04945018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04945018, "A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04945018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*